DiaCarta to Provide VEXAS Syndrome Testing for Veterans Via VA Diagnostic Contract
DiaCarta secured a contract with the San Francisco VA Health Care System to provide VEXAS syndrome testing for veterans.
Read MorePosted by Andy Lundin | Oct 4, 2024 | Allergy & Autoimmune |
DiaCarta secured a contract with the San Francisco VA Health Care System to provide VEXAS syndrome testing for veterans.
Read MorePosted by Andy Lundin | Sep 30, 2024 | Molecular Diagnostic Analyzers |
The digital PCR system brings precise DNA and RNA quantification to diagnostics for applications like cancer monitoring and liquid biopsies.
Read MorePosted by Andy Lundin | Sep 27, 2024 | Infectious Diseases, Molecular Diagnostics |
The Molecular Culture ID is a new diagnostic test that rapidly detects and identifies over 200 bacterial species from various bodily samples.
Read MorePosted by Chris Wolski | Sep 25, 2024 | Colorectal |
Stool-based tests are promising alternatives to colonoscopy for colorectal cancer screening, addressing global accessibility challenges.
Read MorePosted by Andy Lundin | Sep 24, 2024 | Flu & Respiratory Infections |
Roche introduced the cobas Respiratory flex test which uses TAGS technology to identify up to 15 pathogens in a single PCR test.
Read More